196 related articles for article (PubMed ID: 16533469)
1. Thiopurines in inflammatory bowel disease: new strategies for optimization of pharmacotherapy?
Derijks LJ; Hommes DW
Curr Gastroenterol Rep; 2006 Apr; 8(2):89-92. PubMed ID: 16533469
[No Abstract] [Full Text] [Related]
2. Analytical Pitfalls of Therapeutic Drug Monitoring of Thiopurines in Patients With Inflammatory Bowel Disease.
Simsek M; Meijer B; Mulder CJJ; van Bodegraven AA; de Boer NKH
Ther Drug Monit; 2017 Dec; 39(6):584-588. PubMed ID: 29040228
[TBL] [Abstract][Full Text] [Related]
3. Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations.
Al Hadithy AF; de Boer NK; Derijks LJ; Escher JC; Mulder CJ; Brouwers JR
Dig Liver Dis; 2005 Apr; 37(4):282-97. PubMed ID: 15788214
[TBL] [Abstract][Full Text] [Related]
4. The role of thiopurine metabolite monitoring in inflammatory bowel disease.
Beswick L; Friedman AB; Sparrow MP
Expert Rev Gastroenterol Hepatol; 2014 May; 8(4):383-92. PubMed ID: 24684593
[TBL] [Abstract][Full Text] [Related]
5. Azathioprine: when less is more.
Duley JA; Florin TH
J Gastroenterol Hepatol; 2008 Sep; 23(9):1317-9. PubMed ID: 18853992
[No Abstract] [Full Text] [Related]
6. [Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects].
Schwab M; Herrlinger K; Schaeffeler E; Stange EF
Dtsch Med Wochenschr; 2003 Feb; 128(8):378-85. PubMed ID: 12594624
[No Abstract] [Full Text] [Related]
7. Pharmacogenomics and IBD: TPMT and thiopurines.
Sandborn WJ
Inflamm Bowel Dis; 2004 Feb; 10 Suppl 1():S35-7. PubMed ID: 15168829
[No Abstract] [Full Text] [Related]
8. Review article: thiopurines in inflammatory bowel disease.
Derijks LJ; Gilissen LP; Hooymans PM; Hommes DW
Aliment Pharmacol Ther; 2006 Sep; 24(5):715-29. PubMed ID: 16918876
[TBL] [Abstract][Full Text] [Related]
9. Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives.
de Boer NKH; Peyrin-Biroulet L; Jharap B; Sanderson JD; Meijer B; Atreya I; Barclay ML; Colombel JF; Lopez A; Beaugerie L; Marinaki AM; van Bodegraven AA; Neurath MF
J Crohns Colitis; 2018 Apr; 12(5):610-620. PubMed ID: 29293971
[TBL] [Abstract][Full Text] [Related]
10. Why measure thiopurine methyltransferase activity? Direct administration of 6-thioguanine might be the alternative for 6-mercaptopurine or azathioprine.
de Jong D; Mulder CJ; van Sorge AA
Gut; 2001 Dec; 49(6):874. PubMed ID: 11758505
[No Abstract] [Full Text] [Related]
11. Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease.
Kwan LY; Devlin SM; Mirocha JM; Papadakis KA
Dig Liver Dis; 2008 Jun; 40(6):425-32. PubMed ID: 18304898
[TBL] [Abstract][Full Text] [Related]
12. Novel assay to improve therapeutic drug monitoring of thiopurines in inflammatory bowel disease.
Vikingsson S; Andersson D; Almer S; Peterson C; Hindorf U
J Crohns Colitis; 2014 Dec; 8(12):1702-9. PubMed ID: 25239576
[TBL] [Abstract][Full Text] [Related]
13. Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease.
Lowry PW; Franklin CL; Weaver AL; Pike MG; Mays DC; Tremaine WJ; Lipsky JJ; Sandborn WJ
Gut; 2001 Nov; 49(5):665-70. PubMed ID: 11600469
[TBL] [Abstract][Full Text] [Related]
14. How are thiopurines used and monitored by Swedish gastroenterologists when treating patients with inflammatory bowel disease?
Hindorf U; Andersson P
Scand J Gastroenterol; 2011 Oct; 46(10):1215-21. PubMed ID: 21793634
[TBL] [Abstract][Full Text] [Related]
15. Observations on the use of allopurinol in combination with azathioprine or mercaptopurine.
Duley JA; Chocair PR; Florin TH
Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1161-2. PubMed ID: 16305731
[No Abstract] [Full Text] [Related]
16. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
Gearry RB; Barclay ML
J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
[TBL] [Abstract][Full Text] [Related]
17. Differences between children and adults in thiopurine methyltransferase activity and metabolite formation during thiopurine therapy: possible role of concomitant methotrexate.
Pettersson B; Almer S; Albertioni F; Söderhäll S; Peterson C
Ther Drug Monit; 2002 Jun; 24(3):351-8. PubMed ID: 12021625
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a novel TPMT mutation associated with azathioprine-induced myelosuppression.
de Beaumais TA; Fakhoury M; Pigneur B; Viola S; Medard Y; Broly F; Jacqz-Aigrain E
Br J Clin Pharmacol; 2009 Nov; 68(5):770-2. PubMed ID: 19917002
[No Abstract] [Full Text] [Related]
19. Liquid chromatography-tandem mass spectrometry analysis of erythrocyte thiopurine nucleotides and effect of thiopurine methyltransferase gene variants on these metabolites in patients receiving azathioprine/6-mercaptopurine therapy.
Dervieux T; Meyer G; Barham R; Matsutani M; Barry M; Boulieu R; Neri B; Seidman E
Clin Chem; 2005 Nov; 51(11):2074-84. PubMed ID: 16166171
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience of optimising thiopurine use through metabolite measurement in inflammatory bowel disease.
Sánchez Rodríguez E; Ríos León R; Mesonero Gismero F; Albillos A; Lopez-Sanroman A
Gastroenterol Hepatol; 2018 Dec; 41(10):629-635. PubMed ID: 30107940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]